GlobeStar Therapeutics Corporation
OTC: GSTC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- James C. Katzaroff
- Headquarters
- Richland, United States
- IPO year
- 2011
- Market cap
- $124.1K
- Website
- https://www.globestarthera.com
Loading GSTC…
Loading profile data…Frequently asked questions about GSTC
What does GlobeStar Therapeutics Corporation (GSTC) do?
GlobeStar Therapeutics Corporation is a clinical-stage biopharmaceutical firm dedicated to advancing proprietary drug formulations. These innovative treatments specifically target multiple sclerosis (MS) and various other neurodegenerative disorders. Established in 2016, the company was formerly known as AngioSoma, Inc., rebranding to GlobeStar...
Where does GSTC trade?
GlobeStar Therapeutics Corporation (GSTC) trades on the Other OTC.
What sector is GSTC in?
GlobeStar Therapeutics Corporation (GSTC) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of GlobeStar Therapeutics Corporation?
James C. Katzaroff is the chief executive officer of GlobeStar Therapeutics Corporation (GSTC).
Where is GlobeStar Therapeutics Corporation headquartered?
GlobeStar Therapeutics Corporation is headquartered in United States.
Does GSTC pay a dividend?
GlobeStar Therapeutics Corporation (GSTC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GSTC go public?
GlobeStar Therapeutics Corporation (GSTC) completed its initial public offering in 2011.